Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2025-12-26 @ 5:01 PM
Study NCT ID:
NCT05560334
Status:
UNKNOWN
Last Update Posted:
2022-09-29
First Post:
2022-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09-08
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-26
First Submit QC Date:
None
Study First Post Date:
2022-09-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-26
Last Update Post Date:
2022-09-29
Last Update Post Date Type:
ACTUAL